Planning for a Successful Rapid Launch
After many years of research, clinical trials and monetary investment, one of the primary goals for every drug launch is expediency.
From time of regulatory approval, all efforts are focused on getting your innovative drug product packed and delivered to patients as soon as possible.
Join this webinar to discover the key considerations when planning a Rapid Launch. Our expert presenters will not only share insight into what makes for a successful Rapid Launch but will provide real life examples of Rapid Launches that have taken place from our US facilities with drug products being packed and ready for distribution within 24 hours of FDA approval.
Tuesday 15th June, 3pm BST
Speakers: Cara Young, Director Business Development and Gregory Lee, Client Services Manager
Director Business Development
Cara is responsible for partnering with pharmaceutical and biotech businesses that are seeking specialized outsourcing strategies. Before joining Almac, she worked in research and development for 15 years. She uses that technical experience today to recognize whether a client’s program is a good fit for Almac’s many drug product capabilities, which range from early clinical development through commercial manufacturing and packaging.
What she enjoys most about her role is seeing drug candidates successfully advance through clinical phases, then rapid launch to the market, and improve patients’ lives. Cara holds a PhD in Pharmaceutical Sciences from Temple University.
Client Services Manager
Greg is responsible for all US New Production Introductions and Commercial Packaging projects at Almac Pharma Services. His team comprises of Product Supply Managers and Project Coordinators, each dedicated to all types of primary and secondary packaging, labelling, and serialization projects. Based on Successful Project Management principles, the Client Services Team customizes each Project Plan to provide personalized, flexible, quality led commercial solutions from orphan drug launches to ongoing high volume commercial product packaging and supply.
After graduating from University of the Sciences in Philadelphia with his Pharmacy degree, Greg has spent his 20+ year career on all facets of a drug life cycle as a Project Manager:
– Phase II-III Clinical Trials, eCOA/ePRO/eClinical Outcome Assessments, End-Point Data Reliability, Rater Training, Trial Efficiency, and RTSM
– Commercial Drug/Device Manufacture and Packaging
– In-patient Hospital and Retail Pharmacy
– Clinical Pharmacology and Drug Information
– Post-approval Formulary and Protocol Management, REMS, SFA/CRM, Patient Access
– Hospital and IDN Contracting and Reimbursement/Loss of Exclusivity Management